Product Description
Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to treat acne vulgaris. It is also used orally to treat acute promyelocytic leukemia (APL). Its isomer, isotretinoin, is also an acne drug. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.
The Tretinoin market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Tretinoin market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Tretinoin Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Tretinoin market are:
GF Health
Genemed Synthesis
Olon S.p.A.
Gyma Laboratories
BASF
Sun Pharma
Chongqing Huabang
IMCoPharma
LGM Pharma
Most important types of Tretinoin products covered in this report are:
0.05% Tretinoin
0.025% Tretinoin
0.02% Tretinoin
0.1% Tretinoin
Most widely used downstream fields of Tretinoin market covered in this report are:
Leukemia
Skin Use
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.